The Global Anti-Inflammatory Therapeutics Market size is forecast to grow from USD 115.41 Billion in 2025 to approximately USD 193.31 Billion by 2035. 

The Global Anti-Inflammatory Therapeutics Market refers to the market responsible for developing, manufacturing, and distributing medications that provide relief from inflammatory conditions that result from both acute and chronic medical conditions. 

This comprehensive market research report provides an in-depth analysis of the Global Anti-Inflammatory Therapeutics Market , with a focused evaluation of industry developments through 2025. The study delivers detailed insights into current market dynamics, emerging trends, growth drivers, competitive landscape, future strategic outlook, and the evolving regulatory key segments.

The  Global Anti-Inflammatory Therapeutics Market  Report identifies emerging business opportunities while supporting informed strategic and tactical decision-making. Designed for stakeholders operating in a highly competitive and rapidly evolving landscape, this study delivers up-to-date market intelligence essential for tracking performance, mitigating risks, and driving sustainable growth and profitability.

Key players in Global Anti-Inflammatory Therapeutics Market

1. Johnson & Johnson
2. Pfizer Inc.
3. AbbVie Inc.
4. F. Hoffmann-La Roche AG
5. AstraZeneca PLC
6. Amgen Inc.
7. Novartis AG
8. Merck & Co., Inc.
9. Sanofi S.A.
10. GlaxoSmithKline plc
11. Bristol-Myers Squibb Company
12. Eli Lilly and Company

Our expert team is consistently working on updated data and information on the key player's related business processes that value the market for future strategies and predictions

Get Access to a Free Copy of Our Latest Sample Report - https://www.decisionsadvisors.com/request-sample/DAR5002

Market Segmentation:

By Drug Class

• Non-Steroidal Anti-Inflammatory Drugs
• Corticosteroids
• Disease-Modifying Anti-Rheumatic Drugs
• Biologics

By Indication

• Arthritis
• Pain Management
• Inflammatory Bowel Disease
• Allergic Rhinitis

Key Insights Covered in the Global Anti-Inflammatory Therapeutics Market Size & Industry Forecast Report (2020–2035):

1. Detailed analysis of the  Global Anti-Inflammatory TherapeuticsMarket Size, production capacity, utilization rate, output trends, capital investment patterns, and regulatory landscape, along with comprehensive profiles of leading market players.

2. Thorough assessment of Global Anti-Inflammatory Therapeutics Market Growth, revenue analysis, historical performance, and forward-looking projections across major regional markets.

3. In-depth Global Anti-Inflammatory Therapeutics Market Industry Analysis covering competitive landscape, company market share, pricing trends, and future opportunity mapping.

4. Strategic evaluation of recent developments including mergers & acquisitions, partnerships, collaborations, joint ventures, geographic expansions, and product launches shaping the Global Anti-Inflammatory Therapeutics Market Share.

5. Comprehensive value chain and supply chain analysis highlighting raw material sourcing, distribution channels, and end-user segmentation.

6. Regional regulatory framework assessment and policy impact analysis influencing the Global Anti-Inflammatory Therapeutics Market Industry Forecast across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

7. Coverage of technological advancements, product innovations, R&D investments, automation trends, and digital transformation influencing long-term  Global Anti-Inflammatory Therapeutics  Market Growth.

Buy this report now:- https://www.decisionsadvisors.com/checkout/select-licence?report_id=DAR5002

Industry Developments:

In March 2026, Johnson & Johnson received approval from the U.S. Food and Drug Administration for Icotyde (icotrokinra), an oral IL-23 receptor inhibitor indicated for moderate-to-severe plaque psoriasis. The therapy marked the first targeted oral peptide in this class, offering a convenient alternative to injectable biologics.

In March 2026, Bristol Myers Squibb received U.S. Food and Drug Administration approval for Sotyktu (deucravacitinib) to treat adults with active psoriatic arthritis. The oral TYK2 inhibitor became the first therapy of its class approved for this indication, expanding treatment options and strengthening innovation.

In March 2026, GlaxoSmithKline received U.S. FDA approval for its drug Lynavoy (linerixibat) to treat cholestatic pruritus in adults with primary biliary cholangitis. The therapy was reported as the first approved treatment specifically targeting this debilitating itch condition, marking a notable advancement in autoimmune and inflammatory-related liver disease management.

Regional Analysis for Global Anti-Inflammatory Therapeutics Market:

✫ North America: (U.S., Canada, Mexico)
✫ Europe: (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
✫ Asia-Pacific: (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
✫ South America: (Colombia, Brazil, Argentina, Rest of South America)
✫ Middle East & Africa: (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

⏩ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.
⏩ Top-down and bottom-up approach for regional analysis
⏩ Porter’s five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.
⏩ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market

Frequently asked questions:

➥ What is the market size of the Global Anti-Inflammatory Therapeutics Market 
➥ What is the market growth rate of the Global Anti-Inflammatory Therapeutics  market?
➥ What are the Global Anti-Inflammatory Therapeutics Market market opportunities and threats faced by the vendors in the Global Anti-Inflammatory Therapeutics Market Industry?
➥ Which application/end-user or product type may seek incremental growth prospects? What is the market share of each type and application?
➥ What focused approach and constraints are holding the Global Anti-Inflammatory Therapeutics Market ?
➥ What are the different sales, marketing, and distribution channels in the global industry?

Unlock the full report now! @ https://www.decisionsadvisors.com/reports/anti-inflammatory-therapeutics-market

About the Decisions Advisors

Decisions Advisors is a comprehensive market research and consulting company that provides actionable insights based on data. We deal with businesses from various industries and deliver a market intelligence, competitive analysis, forecasting, and bespoke consulting. We also conduct bespoke consulting for our clients.

We provides well-supported advice and intelligence on how businesses can operate in a given market and succeed in achieving their goals.

Contact Us:

Company Name: Decision Advisors

Email: [email protected]

Phone: +1 303 800 4326 (US)

Follow Us: LinkedIn | Facebook | Twitter